Dr David Fuller is the senior vice president of clinical development at Sydney-based Syneos Health Clinical Solutions, and is responsible for growth and strategy of Oncology in the Asia Pacific Region. Dr Fuller is a biopharmaceutical executive and pharmaceutical physician with an impressive record of developing and commercialising new products, as well as establishing and nurturing businesses in complex international environments. His R&D experience encompasses pre-clinical, clinical development, and medical & regulatory affairs. He also has diverse therapeutic expertise spanning rheumatology, renal medicine, oncology, CNS/analgesia, dermatology, gastroenterology and infectious disease products. Dr Fuller led five product approvals (US/EU) and multiple FDA & EMEA interactions for orphan & major market products.
